Schally A V, Guoth J G, Redding T W, Groot K, Rodriguez H, Szonyi E, Stults J, Nikolics K
Endocrine, Polypeptide and Cancer Institute, Veterans Administration Medical Center, New Orleans, LA 70146.
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3540-4. doi: 10.1073/pnas.88.9.3540.
Two peptides with in vitro prolactin release-inhibiting activity were purified from stalk median eminence (SME) fragments of 20,000 pig hypothalami. Monolayer cultures of rat anterior pituitary cells were incubated with aliquots of chromatographic fractions and the inhibition of release of prolactin in vitro was measured by RIA in order to monitor the purification. The hypothalamic tissue extract was separated into 11 fractions by high-performance aqueous size-exclusion chromatography with one fraction showing a 4-fold increase in prolactin release-inhibiting factor (PIF) activity. This material was further purified by semipreparative reversed-phase (RP) HPLC. This process resulted in the separation of two distinct fractions that showed high PIF activity. These were further purified by semipreparative and analytical RP-HPLC to apparent homogeneity as judged by the UV absorbance profiles. Neither of the two peptides showed cross-reactivity with gonadotropin releasing hormone-associated peptide or with somatostatin-14 antibodies. Protein sequence analysis revealed that one of the PIF peptides was Trp-Cys-Leu-Glu-Ser-Ser-Gln-Cys-Gln-Asp-Leu-Ser-Thr-Glu-Ser-Asn-Leu-Leu- Ala-Cys - Ile-Arg-Ala-Cys-Lys-Pro, identical to residues 27-52 of the N-terminal region of the proopiomelanocortin (POMC) precursor (corresponding to amino acids 1-26 of the 16-kDa fragment). The sequence of the other PIF was Ala-Ser-Asp-Arg-Ser-Asn-Ala-Thr-Leu-Leu-Asp-Gly-Pro-Ser-Gly-Ala-Leu-Leu- Leu-Arg - Leu-Val-Gln-Leu-Ala-Gly-Ala-Pro-Glu-Pro-Ala-Glu-Pro-Ala-Gln-Pro-Gly-Val- Tyr, representing residues 109-147 of the vasopressin-neurophysin precursor. Synthetic peptides corresponding to the N-terminal region of POMC had significant PIF activity in vitro.
从20000头猪下丘脑的正中隆起(SME)片段中纯化出两种具有体外催乳素释放抑制活性的肽。将大鼠垂体前叶细胞单层培养物与色谱馏分的等分试样一起孵育,并通过放射免疫分析(RIA)测量体外催乳素释放的抑制情况,以监测纯化过程。下丘脑组织提取物通过高效水相尺寸排阻色谱法分离成11个馏分,其中一个馏分的催乳素释放抑制因子(PIF)活性增加了4倍。该物质通过半制备反相(RP)高效液相色谱进一步纯化。此过程导致分离出两个具有高PIF活性的不同馏分。通过半制备和分析RP - HPLC将它们进一步纯化至表观均一,这是根据紫外吸收图谱判断的。这两种肽均未显示与促性腺激素释放激素相关肽或生长抑素 - 14抗体发生交叉反应。蛋白质序列分析表明,其中一种PIF肽为Trp - Cys - Leu - Glu - Ser - Ser - Gln - Cys - Gln - Asp - Leu - Ser - Thr - Glu - Ser - Asn - Leu - Leu - Ala - Cys - Ile - Arg - Ala - Cys - Lys - Pro,与阿黑皮素原(POMC)前体N端区域的27 - 52位残基相同(对应于16 kDa片段的1 - 26位氨基酸)。另一种PIF的序列为Ala - Ser - Asp - Arg - Ser - Asn - Ala - Thr - Leu - Leu - Asp - Gly - Pro - Ser - Gly - Ala - Leu - Leu - Leu - Arg - Leu - Val - Gln - Leu - Ala - Gly - Ala - Pro - Glu - Pro - Ala - Glu - Pro - Ala - Gln - Pro - Gly - Val - Tyr,代表血管加压素 - 神经垂体素前体的109 - 147位残基。对应于POMC N端区域的合成肽在体外具有显著的PIF活性。